Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma

Kidney International

Volumn 55, Issue 4, 1999, Pages 1375-1383

  Tominaga, Yoshihiro ^a,b,c   Tsuzuki, Toyonori ^a,b,c   Uchida, Kazuharu ^a,b,c   Haba, Toshihito ^a,b,c   Otsuka, Satoki ^a,b,c   Ichimori, Toshihiro ^a,b,c   Yamada, Kazuhiro ^a,b,c   Numano, Masahiro ^a,b,c   Tanaka, Yuji ^a,b,c   Takagi, Hiroshi ^a,b,c  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b Kakegawa City General Hospital   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Nodular hyperplasia; Parathyroid adenoma; Secondary hyperparathyroidism; Tumorigenesis; Uremia

Indexed keywords

CYCLIN D1; GENE PRODUCT; KI 67 ANTIGEN;

ADULT; ARTICLE; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID HYPERPLASIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0032954756     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00396.x     Document Type: Article

References (34)

1. LLACH F: Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited. Am J Kidney Dis 25:663-679, 1995
2. FUKUDA N, TANAKA H, TOMINAGA Y, FUKAGAWA M, KUROKAWA K, SEINO Y: Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443, 1993
3. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598-1606, 1996
4. TOMINAGA Y, SATO K, TANAKA Y, NUMANO M, UCHIDA K, TAKAGI H: Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 44(Suppl 1):S42-S47, 1995
5. TOMINAGA Y, TANAKA Y, SATO K, NAGASAKA T, TAKAGI H: Histopathology, pathophysiology and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13:78-86, 1997
6. TOMINAGA Y, TANAKA T, SATO K, NUMANO M, UCHIDA K, FALKMER U, GRIMELIUS L, JOHANSSON H, TAKAGI H: Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16:595-603, 1992
7. TOMINAGA Y, KOHARA S, NAMJI Y, NAGASAKA T, HABA T, UCHIDA K, NUMANO Y, TANAKA Y, TAKAGI H: Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 20:744-752, 1996
8. ARNOLD A, BROWN MF, URENA P, GAZ RD, SAKEATI E, DRUEKE T: Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047-2053, 1995
9. TOMINAGA Y, TAKAGI H: Molecular genetics of hyperparathyroid disease. Curr Opin Nephrol Hypertens 5:336-341, 1996
10. ARNOLD A, STAUNTON CE, KIM HG, GAZ RD, KRONENBERG HM: Monoclonality and abnormal parathyroid hormone gene in parathyroid adenomas. N Engl J Med 318:658-662, 1988
11. ARNOLD A, KIM HG, GAZ RD, EDDY RL, FUKUSHIMA Y, BYERS M, SHOWAS TB, KRONENBERG HM: Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 3:2034-2040, 1989
12. MOTOKURA T, BLOOM T, KIM HG, JUPPNER H, RUDERMAN JV, KRONENBERG HM, ARNOLD A: A novel cyclin encoded by a bell-linked candidate oncogene. Nature 350:512-515, 1991
13. ROSENBERG CL, KIM HG, SHOWS TB, KRONENBERG HM, ARNOLD A: Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 6:449-453, 1991
14. HIRAMA T, KOEFFLER P: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841-854, 1995
15. TOMINAGA Y, NUMANO M, TANAKA Y, UCHIDA K, TAKAGI H: Surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13:87-96, 1997
16. BANNO S, YOSHIKAWA K, NAKAMURA S, YAMAMOTO K, SEITO T, NITTA M, TAKAHASHI T, UEDA R, SETO M: Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus. Jpn J Cancer Res 85:918-926, 1994
17. SCHUURING E, VERHOEVEN E, MOOI WJ, MICHALIDES JAM: Identification and cloning of two overexpression genes, US1B31/PRAD1 and EMS1, within the amplified chromosome 11Q13 region in human carcinomas. Oncogene 7:355-361, 1992
18. ZHANG SY, CAAMANO J, COOPER F, GUO X, KLEIN-SZANTO A: Immunohistochemistry of cyclin D1 human breast cancer. Anat Pathol 102:695-698, 1994
19. SUTHERLAND R, WATTS CKW, MUSGROVE A: Cyclin gene expression and growth control in normal and neoplastic human breast epithelium. J Steroid Biochem Mol Biol 47:99-106, 1993
20. NISHIDA N, FUKUDA Y, KOMEDA T, KITA R, SANDO T, FURUKAWA M, AMENOMORI M, SHIBAGAKI I, NAKAO K, IKENAGA M, ISHIZAKI K: Amplification and overexpression of cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54:3107-3110, 1994
21. BOSCH F, JARES P, CAMPO E, LOPEZ-GUILLERMO A, PIRIS MA, VILLAMOR N, TASSIES D, JAFFE ES, MONTSERRAT E, ROZMAN C, CARDESA A: PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 84:2726-2732, 1994
22. YANG W, ZUKERBERG LR, MOTOKURA T, ARNOLD A, HARRIS NL: Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86-96, 1994
23. HSI ED, ZUKERBERG LR, YANG WI, ARNOLD A: Cyclin D1/PRAD1 expression in parathyroid adenomas: An immunohistochemical study. J Clin Endocrinol Metab 81:1736-1739, 1996
24. WILLIAMS ME, SWERDLOW SH, ROSENBERG CL, ARNOLD A: Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 7:241-245, 1993
25. BIANCHI AB, FISCER SM, ROBLES AI, RINCHIK EM, CONTI C: Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 11:4846-4853, 1993
26. ARNOLD A, KIM HG: Clonal loss of one chromosome 11 in a parathyroid adenoma. J Clin Endocrinol Metab 69:496-499, 1989
27. BYSTROM C, LARSSON C, BLOMBERG C, SANDELIN K, FALKMER U, SKOGSEID B, OBERG K, WERNER S, NORDENSKJOLD M: Localization of the MEN 1 gene to small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acta Sci USA 87:968-990, 1990
28. FRIEDMAN E, SAKAGUCHI K, BALE AE, FALGHETTI A, STREETEN E, ZIMERING MB, WEINSTEIN LE, MCBRIDE WO, NAKAMURA Y, BRANDI ML, NORTON JA, AURBACH G, SPIEGEL AM, MARX SJ: Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321:213-218, 1990
29. FARNEBO F, TEH BT, DOTZENRATH C, WASSIF WS, SVENSSON A, WHITE I, BETZ R, GORETZKI P, SANDELIN K, FARNEBO LO, LARSSON C: Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism. Hum Genet 99:342-349, 1997
30. CRYNS VL, YI SM, TAMARA H, GAZ RD, ARNOLD A: Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosom Cancer 13:9-17, 1995
31. TAHARA H, SMITH AP, GAZ RD, CRYNS VL, ARNOLD A: Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenoma. Cancer Res 56:599-605, 1996
32. BIANCHI S, FABIANI S, MURATORI M, ARNOLD A, SAKAGUCHI K, MIKI T, BRANDI ML: Calcium moderates the cyclin D1 expression in a rat parathyroid cell line. Biochem Biophys Res Commun 204:691-700, 1994
33. GOGUSEV J, DUCHAMBON P, HORY B, GIOVANNINl M, GOUREAU Y, SARFATI E, DRUEKE TB: Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51:328-336, 1997
34. LIU M, LEE MH, COHEN M, BOMMAKANTI M, FREEDMAN LP: Transcriptional activation of the cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142-153, 1996